Sinebo Woldeyesus, Maredia Karim
a NEPAD Agency African Biosafety Network of Expertise, Kampala Node, UNCST , Ntinda , Kampala , Uganda.
b College of Agriculture and Natural Resources, Michigan State University , East Lansing , MI , USA.
GM Crops Food. 2016 Jan 2;7(1):1-11. doi: 10.1080/21645698.2016.1151989.
The regulation of genetically modified (GM) crops is a topical issue in agriculture and environment over the past 2 decades. The objective of this paper is to recount regulatory and adoption practices in some developing countries that have successfully adopted GM crops so that aspiring countries may draw useful lessons and best practices for their biosafatey regulatory regimes. The first 11 mega-GM crops growing countries each with an area of more than one million hectares in 2014 were examined. Only five out of the 11 countries had smooth and orderly adoption of these crops as per the regulatory requirement of each country. In the remaining 6 countries (all developing countries), GM crops were either introduced across borders without official authorization, released prior to regulatory approval or unapproved seeds were sold along with the approved ones in violation to the existing regulations. Rapid expansion of transgenic crops over the past 2 decades in the developing world was a result of an intense desire by farmers to adopt these crops irrespective of regulatory roadblocks. Lack of workable biosafety regulatory system and political will to support GM crops encouraged unauthorized access to GM crop varieties. In certain cases, unregulated access in turn appeared to result in the adoption of substandard or spurious technology which undermined performance and productivity. An optimal interaction among the national agricultural innovation systems, biosafety regulatory bodies, biotech companies and high level policy makers is vital in making a workable regulated progress in the adoption of GM crops. Factoring forgone opportunities to farmers to benefit from GM crops arising from overregulation into biosafety risk analysis and decision making is suggested. Building functional biosafety regulatory systems that balances the needs of farmers to access and utilize the GM technology with the regulatory imperatives to ensure adequate safety to the environment and human health is recommended.
在过去二十年里,转基因作物的监管一直是农业和环境领域的热门话题。本文旨在讲述一些成功采用转基因作物的发展中国家的监管和采用情况,以便有意愿的国家可以为其生物安全监管制度汲取有益的经验教训和最佳做法。对2014年种植面积超过100万公顷的前11个种植转基因作物大国进行了考察。在这11个国家中,只有5个国家按照各国的监管要求顺利有序地采用了这些作物。在其余6个国家(均为发展中国家),转基因作物要么未经官方授权就跨境引入,要么在监管批准之前就已发布,要么违规将未经批准的种子与已批准的种子一起出售。过去二十年来,转基因作物在发展中世界的迅速扩张是农民不顾监管障碍而强烈渴望采用这些作物的结果。缺乏可行的生物安全监管系统以及支持转基因作物的政治意愿,助长了未经授权获取转基因作物品种的行为。在某些情况下,不受监管的获取反过来似乎导致采用了不合格或虚假的技术,从而损害了性能和生产力。国家农业创新系统、生物安全监管机构、生物技术公司和高级政策制定者之间的最佳互动对于在采用转基因作物方面取得可行的监管进展至关重要。建议将因过度监管而使农民无法从转基因作物中受益的机会成本纳入生物安全风险分析和决策过程。建议建立功能性生物安全监管系统,在平衡农民获取和利用转基因技术的需求与确保对环境和人类健康有足够安全保障的监管要求之间找到平衡。